研究稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的疗效
|
摘要
目的研究分析对老年人冠心病心律失常患者应用稳心颗粒联合美托洛尔进行治疗的临床效果。方法择取在2016年8月至2018年8月到我院就诊的120例老年冠心病心律失常患者,随机划分为60例甲组、60例乙组,统计临床治疗总有效率以及不良反应发生情况。结果甲组临床治疗总有效率为73.33%,乙组为95.00%,经对比分析乙组临床治疗总有效率更高(P<0.05);甲组不良反应发生率为5.00%,乙组为6.67%,经对比分析两组不良反应发生率比较(P>0.05)。结论在临床中,针对老年冠心病心律失常患者而言,对其行稳心颗粒联合美托洛尔进行治疗的效果理想,且具有较高的安全性,应当推广以及借鉴。
Objective To study the clinical effect of treatment of coronary heart disease patients with arrhythmia with Wenxin granules combined with metoprolol. Methods A total of 120 elderly patients with coronary heart disease and arrhythmia who were admitted to our hospital from August 2016 to August 2018 were randomly divided into 60 patients with A group and 60 patients with B. The total effective rate of clinical treatment and the incidence of adverse reactions were statistically analyzed. Results The total effective rate was 73.33% in group A and 95.00% in group B. The total effective rate was higher in group B(P<0.05). The incidence of adverse reactions in group A was 5.00%. Group B was 6.67%, the incidence of adverse reactions were compared between the two groups(P>0.05). Conclusion In the clinical practice, for patients with coronary heart disease and arrhythmia in the elderly, the treatment of Wenxin granule combined with metoprolol is ideal and has high safety. It should be promoted and used for reference.
Objective To study the clinical effect of treatment of coronary heart disease patients with arrhythmia with Wenxin granules combined with metoprolol. Methods A total of 120 elderly patients with coronary heart disease and arrhythmia who were admitted to our hospital from August 2016 to August 2018 were randomly divided into 60 patients with A group and 60 patients with B. The total effective rate of clinical treatment and the incidence of adverse reactions were statistically analyzed. Results The total effective rate was 73.33% in group A and 95.00% in group B. The total effective rate was higher in group B(P<0.05). The incidence of adverse reactions in group A was 5.00%. Group B was 6.67%, the incidence of adverse reactions were compared between the two groups(P>0.05). Conclusion In the clinical practice, for patients with coronary heart disease and arrhythmia in the elderly, the treatment of Wenxin granule combined with metoprolol is ideal and has high safety. It should be promoted and used for reference.
引文
[1]刘建强.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J].医学信息,2016,29(13):99-100.
[2]张合民,孙艳霞,蔡自力.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J].现代诊断与治疗,2016,27(20):3839-3840.
[3]周和寅.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效研究[J].当代医学,2016,22(27):152-153.
[4]郭绍敏.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效分析[J].医药前沿,2016,6(22):221-222.
[5]曾志广.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J].海峡药学,2016,28(3):168-169.
[6]李宁.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的疗效观察[J].中西医结合心脑血管病杂志,2016,14(14):1641-1643.
[7]董学军.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J].中国医药指南,2017,15(6):187-188.
[8]王国菊,陈运海,毛丽娟.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的疗效及其安全性分析[J].中国生化药物杂志,2017,37(6):325-327.
[9]闫生玲.稳心颗粒联合美托洛尔治疗老年冠心病合并心律失常的疗效评价[J].海峡药学,2016,28(8):190-191.
[10]张艳.稳心颗粒联合美托洛尔治疗老年冠心病心律失常患者临床研究[J].现代诊断与治疗,2016,27(13):2425-2426.
[11]李慧滔.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的疗效[J].临床研究,2016,24(9):63-64.
[12]王蔚蔚,刘博雷.稳心颗粒联合美托洛尔治疗老年冠心病心律失常的疗效观察[J].临床医学,2016,36(1):45-46.
[2]张合民,孙艳霞,蔡自力.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J].现代诊断与治疗,2016,27(20):3839-3840.
[3]周和寅.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效研究[J].当代医学,2016,22(27):152-153.
[4]郭绍敏.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效分析[J].医药前沿,2016,6(22):221-222.
[5]曾志广.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J].海峡药学,2016,28(3):168-169.
[6]李宁.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的疗效观察[J].中西医结合心脑血管病杂志,2016,14(14):1641-1643.
[7]董学军.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察[J].中国医药指南,2017,15(6):187-188.
[8]王国菊,陈运海,毛丽娟.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的疗效及其安全性分析[J].中国生化药物杂志,2017,37(6):325-327.
[9]闫生玲.稳心颗粒联合美托洛尔治疗老年冠心病合并心律失常的疗效评价[J].海峡药学,2016,28(8):190-191.
[10]张艳.稳心颗粒联合美托洛尔治疗老年冠心病心律失常患者临床研究[J].现代诊断与治疗,2016,27(13):2425-2426.
[11]李慧滔.稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的疗效[J].临床研究,2016,24(9):63-64.
[12]王蔚蔚,刘博雷.稳心颗粒联合美托洛尔治疗老年冠心病心律失常的疗效观察[J].临床医学,2016,36(1):45-46.